Form D Explorer

Form C-AR — Deverra Therapeutics, Inc.

0001665160-25-000587 · filed 2025-04-10

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
1822782
Entity
Corporation
Jurisdiction
DE
Address
2033 6th Ave Suite 600
Seattle, WA 28121
Phone

Most recent fiscal year financials

Total assets
$11,309,048
Cash
Short-term debt
$1,690,073
Long-term debt
Revenues
$3,879,188
COGS
$3,879,188
Taxes paid
Net income
$-3,718,064

View original on SEC EDGAR.